Skip to main content

MoneyWorks4Me

Sarda Proteins - Quaterly Results

09 Nov 2024 Evaluate
Revenue reduced marginally to stand at Rs. 1.40 millions during the quarter ended September 2024. The figure stood at Rs. 0.00 millions during the year-ago period.The Total Profit for the quarter ended September 2024 of Rs. 1.05 millions grew from Rs.-0.05 millions Operating profit Margin for the quarter ended September 2024 improved to 1.05% as compared to -0.05% of corresponding quarter ended September 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 1.40 0.00 0.00 1.40 2.36 -40.68 12.96 57.95 -77.64
Other Income 0.00 0.41 0.00 0.00 0.82 0.00 1.65 1.60 3.12
PBIDT 1.05 -0.05 -2200.00 0.25 -0.07 -457.14 0.18 0.12 50.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 1.05 -0.05 -2200.00 0.25 -0.07 -457.14 0.18 0.12 50.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 1.05 -0.05 -2200.00 0.25 -0.07 -457.14 0.18 0.12 50.00
TAX 0.00 0.00 0.00 0.00 0.00 0.00 -0.01 0.46 -102.17
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.01 0.46 -102.17
PAT 1.05 -0.05 -2200.00 0.25 -0.07 -457.14 0.19 -0.34 -155.88
Equity 17.26 17.26 0.00 17.26 17.26 0.00 17.26 17.26 0.00
PBIDTM(%) 75.00 0.00 0.00 17.86 -2.97 -702.04 1.39 0.21 570.64
Peers
Company Name CMP
Redington 331.10
Adani Enterprises 2717.60
Amrapali Industries 32.90
Maxgrow India 160.05
Rashi Peripheral 657.00
View more..